The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATMA.L Regulatory News (ATMA)

  • There is currently no data for ATMA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Atlas Mara Announces Successful Restructuring

14 Jul 2021 17:13

RNS Number : 2777F
ATLAS Mara Limited
14 July 2021
 

14 July 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Atlas Mara Limited

(the "Company")

Atlas Mara Announces Successful Restructuring

Key Highlights:

· Atlas Mara announces execution of a binding debt restructuring agreement with a significant majority of its creditors

· This milestone provides long-term stability for the Company to implement its strategic review, including its divestment programme and maintain on-going operations

· These actions pertain only to the Group's holding company structure and do not impact the subsidiary banks, whose underlying performance remains strong

· Company continues to make progress on completion of previously announced divestitures

Atlas Mara Limited ("Atlas Mara" or the "Company," and including its subsidiaries, the "Group"), the sub-Saharan African financial services group, hereby provides an update on the outcome of its discussions with bilateral lenders and certain principal holders of the Group's convertible bonds.

 

The Company is pleased to announce that it has entered into a support and override agreement with a significant majority of its creditors in respect of the Company's and ABC Holdings Limited's ("ABCH") financing arrangements (the "Support and Override Agreement" or "restructuring agreement"). Creditors representing 88 per cent. of the aggregate amount of debt outstanding under the Company's direct and contingent financial liabilities agreed to enter the Support and Override Agreement. This includes over 60 per cent. of the principal holders of the Group's convertible bonds.

 

This high level of support from the creditors enables a long-term stable platform to allow the Company to complete its strategic review and divestments program. The restructuring agreement forbears or extends the repayment schedules of the debt of the Company and ABCH, providing additional time for value recovery amid the ongoing challenging macroeconomic environment. As mentioned in prior market announcements, due to impact of the on-going pandemic and macro challenges faced in the markets in which it operates, the Company embarked on the process that now culminates in the execution of this restructuring agreement.

 

The Support and Override Agreement is focused only on the Group's holding company structure and does not include the operating subsidiaries as parties (although they receive certain benefits from the holding companies being parties). The key terms of the Support and Override Agreement include:

· the creditors who are a party to the Support and Override Agreement (the "Participating Creditors") have agreed to forbearances in respect of certain events of default under their relevant facilities while the Support and Override Agreement is effective including (i) non-payment of amounts due under certain of the Company's and ABCH's financing agreements, (ii) any deterioration in the financial or operational performance of the Group as a result of COVID-19, and (iii) any breach of any financial covenant under certain of the Company's and ABCH's financing agreements;

· the Participating Creditors with direct facilities with the Company have agreed to forbearances in respect of the maturities of their facilities to 30 September 2021, with the possibility of further extension;

· the Participating Creditors with direct facilities with ABCH have agreed to waive the maturities of their facilities until 31 December 2022, with the possibility of further extension;

· proceeds received in respect of the Group's on-going strategic divestments will be held by Wilmington Trust, acting as Global Agent, to support repayments of the Company's and ABCH's creditors in accordance with agreed "waterfall" arrangements;

· Participating Creditors have agreed to either support, or not object to, the Company and ABCH proposing a restructuring procedure if required, including a UK restructuring plan, UK scheme of arrangement or a scheme of arrangement under Part IX of the British Virgin Islands Business Companies Act 2004, to ensure that all of the Company's financial creditors become bound by the terms of the Support and Override Agreement;

· the Support and Override Agreement also governs, and provides a stable framework for, the Company's ongoing liquidity needs - current projections show that the Support and Override Agreement will allow the Company to meet its liquidity needs for the duration of the term of the Support and Override Agreement;

· the Support and Override Agreement also requires the Company to consider taking steps to cancel the listing and admission to trading on the London Stock Exchange of the Company's shares in order to reduce costs and administrative burden since the listing does not generate sufficient benefit to the Company, and in the context of the on-going strategic review. The Company will update the market regarding any such delisting and the steps required in order to implement it or other strategic options; and

· the Support and Override Agreement will terminate either automatically, or upon notice from certain Participating Creditors, if specific criteria are not met, such as divestment milestones or any successful liquidation applications.

The Company remains focused on executing on its strategic review and divestiture programme, to maximize value for its creditors and other stakeholders. As previously updated, the Company has entered into agreements with respect to its assets in Mozambique, Rwanda, Tanzania, and Botswana, and hereby provides the following updates. As previously announced, the transaction with respect to its investment in Mozambique was completed in May 2021. The Company has secured regulatory approval for the transactions with respects to its investments in Rwanda and Botswana, and parties are now in the process of concluding pre-completion conditions. Regulatory approval is pending with respect to the transaction with respect to its investment in Tanzania.

 

In parallel, the Company continues discussions with certain creditors with smaller claims and who are not currently party to the Support and Override Agreement. Further, the Company is robustly contesting TLG's liquidation application, which the Company believes is without merit and not in the best interests of the Company's creditors nor TLG itself. As demonstrated by the Support and Override Agreement, the Company continues to have support from a significant majority of its creditors and intends to continue working towards the successful implementation of its restructuring and divestiture programme in order to maximise value for the benefit of its creditors as a whole, and other stakeholders, and as previously announced, recognizing that there is a risk of insufficient value for shareholders if the Company is unable to do so.

As previously updated, these actions pertain only to the Group's holding company structure and do not impact the subsidiary banks, which operations continue in the ordinary course. The Company will update the market with any further material developments in respect of the strategic review including the on-going divestments, the TLG application, and the Support and Override Agreement.

 

Contact Details:

Investors

Kojo Dufu, +1 212 883 4330

 

Media

Apella Advisors, +44(0) 7818 036 579

Anthony Silverman 

 

About Atlas Mara

Atlas Mara Limited (LON: ATMA) is a financial institution listed on the London Stock Exchange. For more information, visit www.atlasmara.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFIRDTISLIL
Date   Source Headline
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
10th Nov 20214:41 pmRNSSecond Price Monitoring Extn
10th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20214:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
25th Oct 20215:50 pmRNSStrategic Update and Voluntary Delisting
11th Oct 20215:51 pmRNSNotice of Results of Meeting of Noteholders
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20214:40 pmRNSSecond Price Monitoring Extn
16th Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20218:51 amRNS2020 Annual Financial Statements
31st Aug 20216:28 pmRNS2020 Year-End Results
25th Aug 20212:49 pmRNSBPR Sale Completion to KCB & Notice to Investors
22nd Jul 202112:35 pmRNSSuccessful Dismissal of TLG Petition
14th Jul 20215:13 pmRNSAtlas Mara Announces Successful Restructuring
1st Jul 20217:30 amRNSSuspension - Atlas Mara Limited
1st Jul 20217:00 amRNSHalt in Trading & Upcoming Reporting
29th Jun 20211:59 pmRNSExtension of Accounting Reference Date
19th May 20217:00 amRNSRestructuring Discussions and Strategic Review
5th May 20217:12 amRNSStrategic Review and Restructuring Discussions
19th Apr 20217:00 amRNSStrategic Transaction with Access Bank Plc
12th Apr 202111:17 amRNSUpdate on Standstill and Statement re Norsad
1st Apr 20217:02 amRNSUpdate on Standstill and In Principle Agreement
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSNotice of Results of Meeting of Noteholders
5th Mar 20216:29 pmRNSVoting Rights & Director/PDMR Shareholding Update
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
17th Feb 20218:34 amRNSUpdate on Standstill and Statement regarding TLG
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:30 amRNSAtlas Mara Addresses Market Rumours
19th Jan 20214:41 pmRNSSecond Price Monitoring Extn
19th Jan 20214:35 pmRNSPrice Monitoring Extension
5th Jan 20216:16 pmRNSNotification of Major Interest in Shares
4th Jan 20215:46 pmRNSRepurchase of Shares and Total Voting Rights
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20205:30 pmRNSReissued Notice to Bondholders
29th Dec 20209:00 amRNSNotice to Bondholders
29th Dec 20207:03 amRNSNew Financing and Standstill Agreement
14th Dec 20206:20 pmRNSNotification of Major Interest in Shares
14th Dec 20206:16 pmRNSNotification of Major Interest in Shares
26th Nov 20207:00 amRNSStrategic Transaction with KCB Group Plc
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.